Sequoia co-leads $30 million investment in MedGenome’s research and diagnostics testing

MedGenome wants to develop research and diagnostics around rare diseases by looking at India’s population of 1.3 billion, and today the company announced funding of $30 million to further its mission. Sequoia Capital India and Sofina co-led the round, with participation from Zodius Capital and several individual investors.